Translational Cancer Research

Papers
(The TQCC of Translational Cancer Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study46
Diagnostic value of double low-dose targeted perfusion CT imaging for the diagnosis of invasive and preinvasive pulmonary ground-glass nodules: systematic review and meta-analysis35
Effects of p-cresol, a uremic toxin, on cancer cells34
Effect of caspase-1 (CASP1) combined with multimodal ultrasound features on the prognosis of breast cancer patients28
Molecular basis of heterogeneity in small cell lung cancer28
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report24
Successful treatment with osimertinib for nonmucinous bronchioloalveolar carcinoma with massive bronchorrhea and respiratory failure: a case report and literature review23
MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis21
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study20
The size and sternal involvement of chest wall resections for malignant disease predict postoperative morbidity20
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma20
Compression of superior vena cava and azygos vein by a giant mediastinal mature cystic teratoma: a case report20
Prognostic significance of B cell senescence-associated genes as risk markers in prostate adenocarcinoma18
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial17
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer17
Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer17
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors17
Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment17
Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma16
Combining Bulk RNA-seq and scRNA-seq data to identify RNA m5C methyltransferases NSUN1: a rising star as a biomarker for cancer diagnosis, prognosis and therapy15
Neoadjuvant therapy bridging percutaneous coronary intervention (PCI) and video-assisted thoracoscopic (VATS) lobectomy: a retrospective study15
The prognostic value and mechanisms of centromere protein M in patients with lung adenocarcinoma15
Utilization of intraoperative indocyanine green fluorescence imaging to identify vascular anatomy in severe pleural adhesions in uniportal video-assisted thoracoscopic surgery: a case report15
Focal pyroptosis-related genes AIM2 and ZBP1 are prognostic markers for triple-negative breast cancer with brain metastases15
Association of branched-chain amino acids and risk of three urologic cancers: a Mendelian randomization study15
Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy14
Development and validation of a clinical diagnostic model for surgical site infection after surgery in patients with gastric cancer14
Treatment of immune checkpoint inhibitor-related colitis: a narrative review14
CLCN3 in mediating the proliferation of human ovarian cancer cells14
A circadian clock gene-related signature for predicting prognosis and its association with sorafenib response in hepatocellular carcinoma14
An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer14
PTPMT1 inhibition induces apoptosis and growth arrest of human SCLC cells by disrupting mitochondrial metabolism13
Rare cases of pulmonary inflammatory myofibroblastic tumors in adult male patients: a case report13
Identification of neuronal synapse-related signatures and potential therapeutic drugs in colorectal cancer based on machine learning algorithms and molecular docking13
Construction of molecular subtypes and prognostic model for breast cancer based on sulfur metabolism-related genes13
Immunotherapy for combined pulmonary fibrosis and emphysema with advanced lung cancer: two case reports and a concise review13
The association between ephrin receptor-A1 expression and survival in patients with cancer: a meta-analysis13
Application of contrast-enhanced ultrasound in the pathological grading and prognosis prediction of hepatocellular carcinoma13
A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma13
OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma13
Key considerations for interpreting patient-reported outcomes in deep inferior epigastric artery perforator flap reconstruction with post-mastectomy radiotherapy13
Gastric cancer prognosis: unveiling autophagy-related signatures and immune infiltrates13
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?13
Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases13
Construction of a prognostic model for lung adenocarcinoma based on necroptosis genes and its exploration of the potential for tumor immunotherapy13
Comparative analysis of the efficacy and accuracy of magnetic resonance imaging (MRI) and contrast-enhanced CT for residual and new lesions after transcatheter arterial chemoembolization (TACE) in pat13
miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer13
Research progress in predicting visceral pleural invasion of lung cancer: a narrative review13
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn12
Clinical pathological characteristics correlation of H3F3A gene mutation in giant cell tumor of bone: a study of 96 cases12
Construction of a prognostic signature for breast cancer based on genes involved in unsaturated fatty acid biosynthesis12
A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance12
ATP5A1 as a potential prognostic biomarker in clear-cell renal cell carcinoma12
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study12
A systematic review and meta-analysis of the effects of muscle relaxation training vs. conventional nursing on the depression, anxiety and life quality of patients with breast cancer12
Undifferentiated embryonic sarcoma of the adult liver with paraneoplastic syndrome: a case report12
Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification11
Problems and countermeasures for surgical resection of primary pulmonary artery intimal sarcoma11
Three-dimensional model to simulate esophagectomy in patients with a mediastinal vascular anomaly: to see is to believe11
Experience with flap repair after vulvar carcinoma resection: a retrospective observational study of 26 cases11
ECSIT inhibits cell death to increase tumor progression and metastasis via p53 in human breast cancer11
Characteristics of lung cancer screening eligible population in the US and prediction of the eligibility with simplified criteria11
The association of tumor diameter with lymph node metastasis and recurrence in patients with endometrial cancer: a systematic review and meta-analysis11
Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma11
Distribution characteristics and prognosis of tumor-infiltrating lymphocytes in the brain metastases of small cell lung cancer: a retrospective cohort study11
Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma11
Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database11
Efficacy, cardiotoxicity and factors affecting pathologic complete response of neoadjuvant chemotherapy with anthracycline-containing verses anthracycline-free regimens plus dual HER2 blockade for HER11
Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1–2M1 renal cell carcinoma10
A novel inflammatory nutrient index for predicting survival outcomes in patients with non-small cell lung cancer10
Analysis and assessment of ferroptosis-related gene signatures and prognostic risk models in skin cutaneous melanoma10
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for resectable esophageal cancer: a systematic review and meta-analysis10
Changes of proportions of circulating lymphocyte subsets in cancer patients after chemotherapy10
Prognostic development and validation of a prediction model based on major histocompatibility complex-related differentially expressed genes in stomach adenocarcinoma10
Telomere-related gene risk model for prognosis prediction in colorectal cancer10
A pan-cancer analysis of the expression of gasdermin genes in tumors and their relationship with the immune microenvironment10
A narrative review of papillary thyroid carcinoma-related long non-coding RNAs and their relevance to malignant tumors10
The pan-cancer landscape of crosstalk between leukocyte transendothelial migration-related genes and tumor microenvironment relevant to prognosis and immunotherapy response9
DNMT3A promotes glioma growth and malignancy via TNF-α/NF-κB signaling pathway9
Advances in genomic biomarkers for lethal metastatic castration-resistant prostate cancer9
The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial9
Development and validation of nomogram-based models for personalized survival assessment in pediatric hepatoblastoma patients9
Allogeneic CAR-T bridging to allo-HSCT as a treatment strategy for refractory adult Burkitt’s lymphoma: a case report9
Oncologic outcome of breast reconstruction after mastectomy in breast cancer: a systematic review and meta-analysis9
Increased expression of HBXIP (LAMTOR5) predicts poor prognosis and is correlated with immune-cell infiltration in glioma9
Stemness-hypoxia genes PPARGC1A, PFKFB3, and SLC2A5 are associated with prognosis and tumor immune microenvironment in hepatocellular carcinoma9
Primary malignant pericardial mesothelioma with a survival of 2.5 years: a case report9
Study on the prevalence and subtypes of human papillomavirus infection among women in the Xuhui District, Shanghai City, China9
Oncologic and obstetric outcomes of a novel nerve-sparing radical trachelectomy while preserving the uterine branches of the pelvic nerves9
Comparison of the short-term outcomes of open and laparoscopic hepatectomy in the treatment of recurrent hepatocellular carcinoma: a single-center retrospective study9
IL-6 promotes metastasis and EMT of non-small cell lung cancer cells by up-regulating FGL1 via STAT3 pathway9
Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma9
Erratum to lncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p9
Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer9
Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer9
Osimertinib-chemotherapy synergy in EGFR-mutant NSCLC: advancing central nervous system control amidst toxicity considerations9
Exploring potential causal genetic variants and genes for endometrial cancer: Open Targets Genetics, Mendelian randomization, and multi-tissue transcriptome-wide association analysis9
EPB41L4A-AS1 regulates cervical cancer by proliferative cells: mendelian randomization and single-cell transcriptomics analyses9
Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database9
High expression of SETDB1 mediated by miR-29a-3p associates with poor prognosis and immune invasion in breast invasive carcinoma9
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells8
Association between human epidermal growth factor receptor 2 status, namely low and zero expression, and prognosis in hormone receptor-positive breast cancer: a single-center retrospective study8
Prediction of mortality in patients with retinoblastoma based on random survival forest: a retrospective cohort analysis using SEER database8
Integrated analysis of coexpression and a tumor-specific ceRNA network revealed a potential prognostic biomarker in breast cancer8
Promotion of Ros-mediated Bax/Cyt-c apoptosis by polyphyllin II leads to suppress growth and aggression of glioma cells8
Inhibitory effects of LOXL2 knockdown on cellular functions of liver cancer stem cells8
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review8
A newly identified pyroptosis-related gene signature for predicting prognosis of patients with hepatocellular cancer8
Tumor-treating fields in combination with sorafenib curtails the growth of colorectal carcinoma by inactivating AKT/STAT3 signaling8
FXR activation suppresses NF-κB signaling, proliferation and migration in cervical cancer cells8
Prognostic significance of chemotherapy response score in predicting outcomes for high-grade serous ovarian carcinoma patients undergoing neoadjuvant chemotherapy8
CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy8
Uterine intravascular leiomyomatosis involves the heart: a case report and literature review8
Construction of a prognosis model of head and neck squamous cell carcinoma pyroptosis and an analysis of immuno-phenotyping based on bioinformatics8
Granzyme B for predicting the durable clinical benefit of anti-PD-1/PD-L1 immunotherapy in patients with non-small cell lung cancer8
Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro7
High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer7
KIF18A and CDK1 as combined therapeutic targets in cervical and endometrial carcinomas: based on bioinformatics analysis and in vitro experiments7
Prognostic significance of alterations in peripheral cellular and humoral immune biomarkers during radiochemotherapy in head and neck cancer patients7
Rationale and design of a prospective, multicenter, cohort study on the evaluation of postoperative Venous ThromboEmbolism incidence in patients with ColoRectal Cancer (CRC-VTE trial)7
Efficacy of relative dose intensity of nab-paclitaxel for the short-term outcomes, survival, and quality of life in patients with advanced pancreatic cancer: a retrospective study7
Identification of hub genes and key modules in laryngeal squamous cell carcinoma7
Durable clinical response to ALK tyrosine kinase inhibitors in ALK-rearranged non-small cell lung cancer: a case report7
Construction and validation of four-metabolism related-long non-coding RNAs as potential signature in prognosis of colon cancer7
Characterization of genomic clones by targeted deep sequencing of ctDNA to monitor liver cancer7
Prognostic value of preoperative combined with postoperative systemic immune-inflammation index for disease-free survival after radical rectal cancer surgery: a retrospective cohort study7
Exosomal microRNAs in lung cancer: a narrative review7
Risk factors, prognostic factors and nomograms for distant metastasis in colorectal neuroendocrine neoplasms: a SEER-based study7
B7-H3 promotes proliferation and migration of lung cancer cells by modulating PI3K/AKT pathway via ENO1 activity7
Predictive model of gene expression regulating invasion and migration of M2 macrophages in breast cancer: clinical prognosis and therapeutic implications7
Identification of Fanconi anemia pathway genes as novel prognostic biomarkers and therapeutic targets for breast cancer7
A novel mesenchymal epithelial transition (MET) inhibitor, CB538, relieves acquired resistance in EGFR-mutated MET-amplified non-small cell lung cancer7
Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges7
A prognostic model for laryngeal squamous cell carcinoma based on the mitochondrial metabolism-related genes7
Herpes simplex virus-thymidine kinase/ganciclovir suppressed the growth of lung adenocarcinoma cells accompanied by premature senescence7
Study on the value of multi-dimensional conformal radiotherapy and functional imaging in tumor bioimaging7
Integrative analysis of CRISPR screening and gene expression data identifies a three-gene prognostic model associated with immune microenvironment in neuroblastoma7
Women’s hormonal health research and care: the times, they are a-changin’7
Development and validation of a prognostic predictive model of pulmonary spindle cell carcinoma from the surveillance, epidemiology and end results database7
Tackling the HuRdle of radioresistance: a radiation perspective on the RNA-binding protein HuR7
Survival analysis of gastric malignancy patients: identifying key prognostic factors7
The expression of programmed cell death ligand 1 (PD-L1) involves in the clinicopathologic characteristics and prognostic implications of testicular germ cell tumor (TGCT): a systematic review and met7
ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cel7
Slamming hepatocellular carcinoma: targeting immunosuppressive macrophages via SLAMF7 reprograms the tumor microenvironment7
Effect of Rhizoma alismatis on the expression of hub genes in the treatment of gastric cancer7
Effect of periplocin on malignant behavior of oral squamous cell carcinoma cells7
Patient outcomes after non-curative endoscopic submucosal dissection for early colorectal cancer: a single-center, retrospective cohort study7
Multimodality treatment for multiple recurrences of cervical cancer after radiotherapy: a case report7
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre7
Expression of copper metabolism-related genes is associated with the tumor immune microenvironment and predicts the prognosis of hepatocellular carcinoma7
Comprehensive analysis of tumor immune-related gene signature for predicting prognosis, immunotherapy, and drug sensitivity in bladder urothelial carcinoma7
Circular RNA circTADA2A promotes the proliferation, invasion, and migration of non-small cell lung cancer cells via the miR-450b-3p/HMGN5 signaling pathway7
Identification and validation of LINC02381 as a biomarker associated with lymph node metastasis in esophageal squamous cell carcinoma6
Optimizing immunotherapy for lung cancer: integrating genetic alterations and the tumor mutational burden to refine patient selection6
Effect of isocenter deviation on volume modulated arc therapy plan results and gamma passing rate in the treatment of cervical cancer6
Novel hypoxia features with appealing implications in discriminating the prognosis, immune escape and drug responses of 947 hepatocellular carcinoma patients6
Screening of postoperative adjuvant chemotherapy-related serum metabolic markers in breast cancer patients based on 1H NMR metabonomics6
Comprehensive profiling of cell subsets of gastric cancer and liver metastasis based on single cell RNA-sequencing analysis6
The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta6
Identifying epithelial-mesenchymal transition-related genes as prognostic biomarkers and therapeutic targets of hepatocellular carcinoma by integrated analysis of single-cell and bulk-RNA sequencing d6
The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation6
Retraction: H19/miR-152-3p/TCF4 axis increases chemosensitivity of gastric cancer cells through suppression of epithelial-mesenchymal transition6
A signature of four ferroptosis-related genes in laryngeal squamous cell carcinoma6
Maximal resection for malignant scalp tumors: is it valuable for long-term follow-up?6
Validation of the interaction between PRDX4 and TXNDC5 in gastric cancer and the significance of the PRDX4 gene in gastric cancer based on a data mining analysis6
Diagnosis and multimodality treatment of primary malignant tracheal tumors6
Erratum: miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer6
Efficacy and safety of chimeric antigen receptor (CAR)-T cell therapy in the treatment of relapsed and refractory multiple myeloma: a systematic-review and meta-analysis of clinical trials6
Radiomic signatures of brain metastases on MRI: utility in predicting pathological subtypes of lung cancer6
Predictive nomograms for risk and prognostic factors in metastatic bladder cancer: a population-based study6
Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review6
Potential added value of computed tomography radiomics to multimodal prediction models for benign and malignant breast tumors6
Comparable prognosis of early gastric cancer between intestinal type and diffuse type in patients of age 75 and older: a SEER-based cohort study6
Efficacy and safety of immune checkpoint inhibitors plus platinum-etoposide vs. platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer: a systematic review and a meta6
Comprehensive analysis of disulfidptosis-related lncRNAs for predicting prognosis and response of immunotherapy in pancreatic adenocarcinoma6
The effects of the tumor suppressor gene PTEN on the proliferation and apoptosis of breast cancer cells via AKT phosphorylation6
Development of a novel colon adenocarcinoma m6A-related lncRNA pair prognostic model6
Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in adenoid cystic carcinoma of the salivary gland6
Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma6
Identification and validation of hypoxia-associated genes positively correlated with HIF1A in pulmonary adenocarcinoma6
Analysis of prognostic and therapeutic values of drug resistance-related genes in the lung cancer microenvironment6
Caveolin-1 is a prognostic marker and suppresses the proliferation of breast cancer6
Suppression of hepatocellular carcinoma progression by long noncoding RNA apolipoprotein C1 pseudogene via the regulation of the microRNA-106b-PTEN axis6
Texture analysis based on PI-RADS 4/5-scored magnetic resonance images combined with machine learning to distinguish benign lesions from prostate cancer6
Construction of a novel disulfidptosis-associated lncRNAs signature for risk features and immunotherapy in breast cancer6
Construction of a competing endogenous RNA network in head and neck squamous cell carcinoma by pan-cancer analysis6
The peripheral CD4+ T cells predict efficacy in non-small cell lung cancer (NSCLC) patients with the anti-PD-1 treatment6
Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death6
Preliminary exploration of the potential biological functions and prognosis values of RAB4B in pan-cancer combing with experimental validation in BLCA6
Prognostic and immunological significance of peroxisome proliferator-activated receptor gamma in hepatocellular carcinoma based on multiple databases6
The impact of the location, incidence and distribution of lung metastases in primary colorectal and renal cell cancer patients on prognosis: a retrospective observational study6
The prognostic value of immune escape-related genes in lung adenocarcinoma6
Proteome-wide identification and functional analysis of ubiquitinated proteins in Hepa1-6 cells by knockdown of E3 ubiquitin ligase SIAH16
Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?6
Winning hearts & minds: prostate cancer outreach and clinical trial enrollment in minority men6
A real-world retrospective cohort study: the clinical outcomes and characteristics of platinum-resistant recurrent ovarian cancer6
Feasibility and safety of transarterial chemoembolization in patients with liver cancer via the distal radial approach: a single-center retrospective cohort study6
Construction and validation of a nomogram prediction model for predicting the risk of chemotherapy-induced myelosuppression after chemotherapy in patients with triple-negative breast cancer: a single-6
Sublobar resection is non-inferior to lobectomy in octogenarians and older with stage Ia non-small cell lung cancer6
FLAURA2: evidence for escalated first-line therapy in EGFR-mutated non-small cell lung cancer with central nervous system metastases6
Fusobacterium nucleatum and IL-32 co-predict nodal metastasis preoperatively in head and neck cancer6
LncRNA OXCT1-AS1 promotes the proliferation of non-small cell lung cancer cells by targeting the miR-195/CCNE1 axis6
Construction of diagnostic and prognostic models based on gene signatures of nasopharyngeal carcinoma by machine learning methods6
Inhibition of autophagy by 3-methyladenine promotes migration and invasion of colon cancer cells through epithelial mesenchymal transformation5
CCND2 is a prognostic biomarker and correlates with immune infiltration in lung adenocarcinoma5
Robotic and video-assisted lobectomy/segmentectomy for non-small cell lung cancer have similar perioperative outcomes: a systematic review and meta-analysis5
Association between family history and prognosis of patients with colorectal cancer: a systematic review and meta-analysis5
First-line treatment of extensive-stage small cell lung cancer with immune checkpoint inhibitors acting on different targets: a systematic review and network meta-analysis5
Genomic analysis of the endosomal sorting required for transport complex III pathway genes as therapeutic and prognostic biomarkers for endometrial carcinoma5
Relationship between Kita-Kyushu Lung Cancer antigen-1 expression and prognosis of cases with lung squamous cell carcinoma5
A potential EBV-related classifier is associated with the efficacy of immunotherapy in gastric cancer5
The benefit of the doubt: PD-L1 status in unresectable stage III NSCLC management5
A novel m6A/m5C/m1A/m7G‐related classification and risk signature predicts prognosis and reveals immunotherapy inclination in gastric cancer5
CircPTN promotes angiogenesis via the MiR-595/LYRM5 signaling pathway in non-small cell lung cancer5
Identifying functional cuproptosis-related long non-coding RNAs in patients with bladder cancer5
Integrated bioinformatics investigation of adenylyl cyclase family co-expression network in bladder cancer followed by preliminary validation of member 2 (ADCY2) in tumorigenesis and prognosis5
From induced pluripotent stem cell (iPSC) to universal immune cells: literature review of advances in a new generation of tumor therapies5
A new risk algorithm combining D-dimer and HE4 differentiates borderline tumor from patients with ovarian tumor5
The roles of lncRNA AP001469.3 in clinical implications, immune landscape and carcinogenesis of colorectal cancer5
A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation5
Clinical characteristics of patients simultaneously diagnosed with lung cancer and active pulmonary tuberculosis in countries where tuberculosis is moderately endemic5
Screening key prognostic factors and constructing survival prognostic risk prediction model based on ceRNA network in early lung adenocarcinoma5
Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes5
Limitations and oncological uncertainties of intraductal laser ablation for pathological nipple discharge5
Feasibility evaluation of kilovoltage cone-beam computed tomography dose calculation following scatter correction: investigations of phantom and representative tumor sites5
Nomogram for predicting the early death of patients with stage IV ovarian cancer: a retrospective analysis of the SEER database5
Pathomics signatures and cuproptosis-related genes signatures for prediction of prognosis in patients with hepatocellular carcinoma5
Identification of the function of FOSB in cholangiocarcinoma using bioinformatics analysis5
Expression of HIF-1α, ANXA3, CD133 and their associations with clinicopathological parameters in human colon carcinoma5
Hemicolectomy versus appendectomy alone for appendiceal neuroendocrine tumours between 1–2 cm in size—are we overtreating?5
Bioactivity of recombinant humanized monoclonal antibody against HER2 in-vivo and in-vitro and its mechanism of action in ovarian cancer5
In silico trials of combination immuno-radiation for unresectable hepatocellular carcinoma5
Intracranial complete response to toripalimab and anlotinib in a patient with recurrent brain metastases of small cell lung cancer after failure of second-line maintenance therapy: a case report5
Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma5
TFF3 promotes clonogenic survival of colorectal cancer cells through upregulation of EP4 via activation of STAT35
Prognostic impact of mitofusin 2 expression in colon cancer5
A predictive nomogram for predicting liver metastasis in early-onset colon cancer: a population-based study5
Construction of a new prognostic model for colorectal cancer based on bulk RNA-seq combined with The Cancer Genome Atlas data5
Immunogenic cell death-related signature predicts prognosis and immunotherapy efficacy in bladder cancer5
Analysis of the distinct features of metastasis male breast cancer and its effect on overall survival based on the SEER database compared with female breast cancer5
Development and validation of a novel ubiquitination-related gene prognostic signature based on tumor microenvironment for colon cancer5
Development and validation a radiomics nomogram for diagnosing occult brain metastases in patients with stage IV lung adenocarcinoma5
Comparison of transbronchial biopsy techniques using needle and forceps biopsies in lung cancer for molecular diagnostics: a prospective, randomized crossover trial5
The influence of antibody CD166 on the treatment of tumor and the immunological mechanism in mice bearing oral squamous cell carcinoma5
Cinnamophilin enhances temozolomide-induced cytotoxicity against malignant glioma: the roles of ROS and cell cycle arrest5
Pregnancy wishes after breast cancer—an unsettled conflict solved?5
Potential diagnostic marker gene set for non-alcoholic steatohepatitis associated hepatocellular carcinoma with lymphocyte infiltration5
Identification and validation of the clinical prediction model and biomarkers based on chromatin regulators in colon cancer by integrated analysis of bulk- and single-cell RNA sequencing data5
Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types5
The diagnostic, prognostic, drug sensitivity and ceRNA internet of PPP4R1 in liver hepatocellular carcinoma (LIHC)5
0.058517932891846